Global Central Nervous System Therapy Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Central Nervous System Therapy Industry Forecast” looks at past sales and reviews total world Central Nervous System Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Central Nervous System Therapy sales for 2023 through 2029. With Central Nervous System Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Central Nervous System Therapy industry.
This Insight Report provides a comprehensive analysis of the global Central Nervous System Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Central Nervous System Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Central Nervous System Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Central Nervous System Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Central Nervous System Therapy.
The global Central Nervous System Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Central Nervous System Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Central Nervous System Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Central Nervous System Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Central Nervous System Therapy players cover Abbvie, Alkermes, Allergan, AstraZeneca, BIAL, Bristol-myers Squibb, Eisai, Endo Pharmaceuticals and Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Central Nervous System Therapy market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Central Nervous System Therapy market?
What factors are driving Central Nervous System Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Central Nervous System Therapy market opportunities vary by end market size?
How does Central Nervous System Therapy break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Central Nervous System Therapy Industry Forecast” looks at past sales and reviews total world Central Nervous System Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Central Nervous System Therapy sales for 2023 through 2029. With Central Nervous System Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Central Nervous System Therapy industry.
This Insight Report provides a comprehensive analysis of the global Central Nervous System Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Central Nervous System Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Central Nervous System Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Central Nervous System Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Central Nervous System Therapy.
The global Central Nervous System Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Central Nervous System Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Central Nervous System Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Central Nervous System Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Central Nervous System Therapy players cover Abbvie, Alkermes, Allergan, AstraZeneca, BIAL, Bristol-myers Squibb, Eisai, Endo Pharmaceuticals and Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Central Nervous System Therapy market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Antidepressant Treatment
- Antipsychotic Therapy
- Other CNS Disorder
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbvie
- Alkermes
- Allergan
- AstraZeneca
- BIAL
- Bristol-myers Squibb
- Eisai
- Endo Pharmaceuticals
- Eli Lilly and Company
- Hoffmann-LA Roche
What is the 10-year outlook for the global Central Nervous System Therapy market?
What factors are driving Central Nervous System Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Central Nervous System Therapy market opportunities vary by end market size?
How does Central Nervous System Therapy break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Central Nervous System Therapy Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Central Nervous System Therapy by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Central Nervous System Therapy by Country/Region, 2018, 2022 & 2029
2.2 Central Nervous System Therapy Segment by Type
2.2.1 Antidepressant Treatment
2.2.2 Antipsychotic Therapy
2.2.3 Other CNS Disorder
2.3 Central Nervous System Therapy Sales by Type
2.3.1 Global Central Nervous System Therapy Sales Market Share by Type (2018-2023)
2.3.2 Global Central Nervous System Therapy Revenue and Market Share by Type (2018-2023)
2.3.3 Global Central Nervous System Therapy Sale Price by Type (2018-2023)
2.4 Central Nervous System Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Central Nervous System Therapy Sales by Application
2.5.1 Global Central Nervous System Therapy Sale Market Share by Application (2018-2023)
2.5.2 Global Central Nervous System Therapy Revenue and Market Share by Application (2018-2023)
2.5.3 Global Central Nervous System Therapy Sale Price by Application (2018-2023)
3 GLOBAL CENTRAL NERVOUS SYSTEM THERAPY BY COMPANY
3.1 Global Central Nervous System Therapy Breakdown Data by Company
3.1.1 Global Central Nervous System Therapy Annual Sales by Company (2018-2023)
3.1.2 Global Central Nervous System Therapy Sales Market Share by Company (2018-2023)
3.2 Global Central Nervous System Therapy Annual Revenue by Company (2018-2023)
3.2.1 Global Central Nervous System Therapy Revenue by Company (2018-2023)
3.2.2 Global Central Nervous System Therapy Revenue Market Share by Company (2018-2023)
3.3 Global Central Nervous System Therapy Sale Price by Company
3.4 Key Manufacturers Central Nervous System Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Central Nervous System Therapy Product Location Distribution
3.4.2 Players Central Nervous System Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CENTRAL NERVOUS SYSTEM THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Central Nervous System Therapy Market Size by Geographic Region (2018-2023)
4.1.1 Global Central Nervous System Therapy Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Central Nervous System Therapy Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Central Nervous System Therapy Market Size by Country/Region (2018-2023)
4.2.1 Global Central Nervous System Therapy Annual Sales by Country/Region (2018-2023)
4.2.2 Global Central Nervous System Therapy Annual Revenue by Country/Region (2018-2023)
4.3 Americas Central Nervous System Therapy Sales Growth
4.4 APAC Central Nervous System Therapy Sales Growth
4.5 Europe Central Nervous System Therapy Sales Growth
4.6 Middle East & Africa Central Nervous System Therapy Sales Growth
5 AMERICAS
5.1 Americas Central Nervous System Therapy Sales by Country
5.1.1 Americas Central Nervous System Therapy Sales by Country (2018-2023)
5.1.2 Americas Central Nervous System Therapy Revenue by Country (2018-2023)
5.2 Americas Central Nervous System Therapy Sales by Type
5.3 Americas Central Nervous System Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Central Nervous System Therapy Sales by Region
6.1.1 APAC Central Nervous System Therapy Sales by Region (2018-2023)
6.1.2 APAC Central Nervous System Therapy Revenue by Region (2018-2023)
6.2 APAC Central Nervous System Therapy Sales by Type
6.3 APAC Central Nervous System Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Central Nervous System Therapy by Country
7.1.1 Europe Central Nervous System Therapy Sales by Country (2018-2023)
7.1.2 Europe Central Nervous System Therapy Revenue by Country (2018-2023)
7.2 Europe Central Nervous System Therapy Sales by Type
7.3 Europe Central Nervous System Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Central Nervous System Therapy by Country
8.1.1 Middle East & Africa Central Nervous System Therapy Sales by Country (2018-2023)
8.1.2 Middle East & Africa Central Nervous System Therapy Revenue by Country (2018-2023)
8.2 Middle East & Africa Central Nervous System Therapy Sales by Type
8.3 Middle East & Africa Central Nervous System Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Central Nervous System Therapy
10.3 Manufacturing Process Analysis of Central Nervous System Therapy
10.4 Industry Chain Structure of Central Nervous System Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Central Nervous System Therapy Distributors
11.3 Central Nervous System Therapy Customer
12 WORLD FORECAST REVIEW FOR CENTRAL NERVOUS SYSTEM THERAPY BY GEOGRAPHIC REGION
12.1 Global Central Nervous System Therapy Market Size Forecast by Region
12.1.1 Global Central Nervous System Therapy Forecast by Region (2024-2029)
12.1.2 Global Central Nervous System Therapy Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Central Nervous System Therapy Forecast by Type
12.7 Global Central Nervous System Therapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbvie
13.1.1 Abbvie Company Information
13.1.2 Abbvie Central Nervous System Therapy Product Portfolios and Specifications
13.1.3 Abbvie Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbvie Main Business Overview
13.1.5 Abbvie Latest Developments
13.2 Alkermes
13.2.1 Alkermes Company Information
13.2.2 Alkermes Central Nervous System Therapy Product Portfolios and Specifications
13.2.3 Alkermes Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Alkermes Main Business Overview
13.2.5 Alkermes Latest Developments
13.3 Allergan
13.3.1 Allergan Company Information
13.3.2 Allergan Central Nervous System Therapy Product Portfolios and Specifications
13.3.3 Allergan Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Allergan Main Business Overview
13.3.5 Allergan Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Central Nervous System Therapy Product Portfolios and Specifications
13.4.3 AstraZeneca Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 BIAL
13.5.1 BIAL Company Information
13.5.2 BIAL Central Nervous System Therapy Product Portfolios and Specifications
13.5.3 BIAL Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 BIAL Main Business Overview
13.5.5 BIAL Latest Developments
13.6 Bristol-myers Squibb
13.6.1 Bristol-myers Squibb Company Information
13.6.2 Bristol-myers Squibb Central Nervous System Therapy Product Portfolios and Specifications
13.6.3 Bristol-myers Squibb Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bristol-myers Squibb Main Business Overview
13.6.5 Bristol-myers Squibb Latest Developments
13.7 Eisai
13.7.1 Eisai Company Information
13.7.2 Eisai Central Nervous System Therapy Product Portfolios and Specifications
13.7.3 Eisai Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Eisai Main Business Overview
13.7.5 Eisai Latest Developments
13.8 Endo Pharmaceuticals
13.8.1 Endo Pharmaceuticals Company Information
13.8.2 Endo Pharmaceuticals Central Nervous System Therapy Product Portfolios and Specifications
13.8.3 Endo Pharmaceuticals Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Endo Pharmaceuticals Main Business Overview
13.8.5 Endo Pharmaceuticals Latest Developments
13.9 Eli Lilly and Company
13.9.1 Eli Lilly and Company Company Information
13.9.2 Eli Lilly and Company Central Nervous System Therapy Product Portfolios and Specifications
13.9.3 Eli Lilly and Company Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Eli Lilly and Company Main Business Overview
13.9.5 Eli Lilly and Company Latest Developments
13.10 Hoffmann-LA Roche
13.10.1 Hoffmann-LA Roche Company Information
13.10.2 Hoffmann-LA Roche Central Nervous System Therapy Product Portfolios and Specifications
13.10.3 Hoffmann-LA Roche Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hoffmann-LA Roche Main Business Overview
13.10.5 Hoffmann-LA Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Central Nervous System Therapy Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Central Nervous System Therapy by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Central Nervous System Therapy by Country/Region, 2018, 2022 & 2029
2.2 Central Nervous System Therapy Segment by Type
2.2.1 Antidepressant Treatment
2.2.2 Antipsychotic Therapy
2.2.3 Other CNS Disorder
2.3 Central Nervous System Therapy Sales by Type
2.3.1 Global Central Nervous System Therapy Sales Market Share by Type (2018-2023)
2.3.2 Global Central Nervous System Therapy Revenue and Market Share by Type (2018-2023)
2.3.3 Global Central Nervous System Therapy Sale Price by Type (2018-2023)
2.4 Central Nervous System Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Central Nervous System Therapy Sales by Application
2.5.1 Global Central Nervous System Therapy Sale Market Share by Application (2018-2023)
2.5.2 Global Central Nervous System Therapy Revenue and Market Share by Application (2018-2023)
2.5.3 Global Central Nervous System Therapy Sale Price by Application (2018-2023)
3 GLOBAL CENTRAL NERVOUS SYSTEM THERAPY BY COMPANY
3.1 Global Central Nervous System Therapy Breakdown Data by Company
3.1.1 Global Central Nervous System Therapy Annual Sales by Company (2018-2023)
3.1.2 Global Central Nervous System Therapy Sales Market Share by Company (2018-2023)
3.2 Global Central Nervous System Therapy Annual Revenue by Company (2018-2023)
3.2.1 Global Central Nervous System Therapy Revenue by Company (2018-2023)
3.2.2 Global Central Nervous System Therapy Revenue Market Share by Company (2018-2023)
3.3 Global Central Nervous System Therapy Sale Price by Company
3.4 Key Manufacturers Central Nervous System Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Central Nervous System Therapy Product Location Distribution
3.4.2 Players Central Nervous System Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CENTRAL NERVOUS SYSTEM THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Central Nervous System Therapy Market Size by Geographic Region (2018-2023)
4.1.1 Global Central Nervous System Therapy Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Central Nervous System Therapy Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Central Nervous System Therapy Market Size by Country/Region (2018-2023)
4.2.1 Global Central Nervous System Therapy Annual Sales by Country/Region (2018-2023)
4.2.2 Global Central Nervous System Therapy Annual Revenue by Country/Region (2018-2023)
4.3 Americas Central Nervous System Therapy Sales Growth
4.4 APAC Central Nervous System Therapy Sales Growth
4.5 Europe Central Nervous System Therapy Sales Growth
4.6 Middle East & Africa Central Nervous System Therapy Sales Growth
5 AMERICAS
5.1 Americas Central Nervous System Therapy Sales by Country
5.1.1 Americas Central Nervous System Therapy Sales by Country (2018-2023)
5.1.2 Americas Central Nervous System Therapy Revenue by Country (2018-2023)
5.2 Americas Central Nervous System Therapy Sales by Type
5.3 Americas Central Nervous System Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Central Nervous System Therapy Sales by Region
6.1.1 APAC Central Nervous System Therapy Sales by Region (2018-2023)
6.1.2 APAC Central Nervous System Therapy Revenue by Region (2018-2023)
6.2 APAC Central Nervous System Therapy Sales by Type
6.3 APAC Central Nervous System Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Central Nervous System Therapy by Country
7.1.1 Europe Central Nervous System Therapy Sales by Country (2018-2023)
7.1.2 Europe Central Nervous System Therapy Revenue by Country (2018-2023)
7.2 Europe Central Nervous System Therapy Sales by Type
7.3 Europe Central Nervous System Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Central Nervous System Therapy by Country
8.1.1 Middle East & Africa Central Nervous System Therapy Sales by Country (2018-2023)
8.1.2 Middle East & Africa Central Nervous System Therapy Revenue by Country (2018-2023)
8.2 Middle East & Africa Central Nervous System Therapy Sales by Type
8.3 Middle East & Africa Central Nervous System Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Central Nervous System Therapy
10.3 Manufacturing Process Analysis of Central Nervous System Therapy
10.4 Industry Chain Structure of Central Nervous System Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Central Nervous System Therapy Distributors
11.3 Central Nervous System Therapy Customer
12 WORLD FORECAST REVIEW FOR CENTRAL NERVOUS SYSTEM THERAPY BY GEOGRAPHIC REGION
12.1 Global Central Nervous System Therapy Market Size Forecast by Region
12.1.1 Global Central Nervous System Therapy Forecast by Region (2024-2029)
12.1.2 Global Central Nervous System Therapy Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Central Nervous System Therapy Forecast by Type
12.7 Global Central Nervous System Therapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbvie
13.1.1 Abbvie Company Information
13.1.2 Abbvie Central Nervous System Therapy Product Portfolios and Specifications
13.1.3 Abbvie Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbvie Main Business Overview
13.1.5 Abbvie Latest Developments
13.2 Alkermes
13.2.1 Alkermes Company Information
13.2.2 Alkermes Central Nervous System Therapy Product Portfolios and Specifications
13.2.3 Alkermes Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Alkermes Main Business Overview
13.2.5 Alkermes Latest Developments
13.3 Allergan
13.3.1 Allergan Company Information
13.3.2 Allergan Central Nervous System Therapy Product Portfolios and Specifications
13.3.3 Allergan Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Allergan Main Business Overview
13.3.5 Allergan Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Central Nervous System Therapy Product Portfolios and Specifications
13.4.3 AstraZeneca Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 BIAL
13.5.1 BIAL Company Information
13.5.2 BIAL Central Nervous System Therapy Product Portfolios and Specifications
13.5.3 BIAL Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 BIAL Main Business Overview
13.5.5 BIAL Latest Developments
13.6 Bristol-myers Squibb
13.6.1 Bristol-myers Squibb Company Information
13.6.2 Bristol-myers Squibb Central Nervous System Therapy Product Portfolios and Specifications
13.6.3 Bristol-myers Squibb Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bristol-myers Squibb Main Business Overview
13.6.5 Bristol-myers Squibb Latest Developments
13.7 Eisai
13.7.1 Eisai Company Information
13.7.2 Eisai Central Nervous System Therapy Product Portfolios and Specifications
13.7.3 Eisai Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Eisai Main Business Overview
13.7.5 Eisai Latest Developments
13.8 Endo Pharmaceuticals
13.8.1 Endo Pharmaceuticals Company Information
13.8.2 Endo Pharmaceuticals Central Nervous System Therapy Product Portfolios and Specifications
13.8.3 Endo Pharmaceuticals Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Endo Pharmaceuticals Main Business Overview
13.8.5 Endo Pharmaceuticals Latest Developments
13.9 Eli Lilly and Company
13.9.1 Eli Lilly and Company Company Information
13.9.2 Eli Lilly and Company Central Nervous System Therapy Product Portfolios and Specifications
13.9.3 Eli Lilly and Company Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Eli Lilly and Company Main Business Overview
13.9.5 Eli Lilly and Company Latest Developments
13.10 Hoffmann-LA Roche
13.10.1 Hoffmann-LA Roche Company Information
13.10.2 Hoffmann-LA Roche Central Nervous System Therapy Product Portfolios and Specifications
13.10.3 Hoffmann-LA Roche Central Nervous System Therapy Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hoffmann-LA Roche Main Business Overview
13.10.5 Hoffmann-LA Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Central Nervous System Therapy Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Central Nervous System Therapy Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Antidepressant Treatment
Table 4. Major Players of Antipsychotic Therapy
Table 5. Major Players of Other CNS Disorder
Table 6. Global Central Nervous System Therapy Sales by Type (2018-2023) & (K Units)
Table 7. Global Central Nervous System Therapy Sales Market Share by Type (2018-2023)
Table 8. Global Central Nervous System Therapy Revenue by Type (2018-2023) & ($ million)
Table 9. Global Central Nervous System Therapy Revenue Market Share by Type (2018-2023)
Table 10. Global Central Nervous System Therapy Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Central Nervous System Therapy Sales by Application (2018-2023) & (K Units)
Table 12. Global Central Nervous System Therapy Sales Market Share by Application (2018-2023)
Table 13. Global Central Nervous System Therapy Revenue by Application (2018-2023)
Table 14. Global Central Nervous System Therapy Revenue Market Share by Application (2018-2023)
Table 15. Global Central Nervous System Therapy Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Central Nervous System Therapy Sales by Company (2018-2023) & (K Units)
Table 17. Global Central Nervous System Therapy Sales Market Share by Company (2018-2023)
Table 18. Global Central Nervous System Therapy Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Central Nervous System Therapy Revenue Market Share by Company (2018-2023)
Table 20. Global Central Nervous System Therapy Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Central Nervous System Therapy Producing Area Distribution and Sales Area
Table 22. Players Central Nervous System Therapy Products Offered
Table 23. Central Nervous System Therapy Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Central Nervous System Therapy Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Central Nervous System Therapy Sales Market Share Geographic Region (2018-2023)
Table 28. Global Central Nervous System Therapy Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Central Nervous System Therapy Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Central Nervous System Therapy Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Central Nervous System Therapy Sales Market Share by Country/Region (2018-2023)
Table 32. Global Central Nervous System Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Central Nervous System Therapy Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Central Nervous System Therapy Sales by Country (2018-2023) & (K Units)
Table 35. Americas Central Nervous System Therapy Sales Market Share by Country (2018-2023)
Table 36. Americas Central Nervous System Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Central Nervous System Therapy Revenue Market Share by Country (2018-2023)
Table 38. Americas Central Nervous System Therapy Sales by Type (2018-2023) & (K Units)
Table 39. Americas Central Nervous System Therapy Sales by Application (2018-2023) & (K Units)
Table 40. APAC Central Nervous System Therapy Sales by Region (2018-2023) & (K Units)
Table 41. APAC Central Nervous System Therapy Sales Market Share by Region (2018-2023)
Table 42. APAC Central Nervous System Therapy Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Central Nervous System Therapy Revenue Market Share by Region (2018-2023)
Table 44. APAC Central Nervous System Therapy Sales by Type (2018-2023) & (K Units)
Table 45. APAC Central Nervous System Therapy Sales by Application (2018-2023) & (K Units)
Table 46. Europe Central Nervous System Therapy Sales by Country (2018-2023) & (K Units)
Table 47. Europe Central Nervous System Therapy Sales Market Share by Country (2018-2023)
Table 48. Europe Central Nervous System Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Central Nervous System Therapy Revenue Market Share by Country (2018-2023)
Table 50. Europe Central Nervous System Therapy Sales by Type (2018-2023) & (K Units)
Table 51. Europe Central Nervous System Therapy Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Central Nervous System Therapy Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Central Nervous System Therapy Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Central Nervous System Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Central Nervous System Therapy Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Central Nervous System Therapy Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Central Nervous System Therapy Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Central Nervous System Therapy
Table 59. Key Market Challenges & Risks of Central Nervous System Therapy
Table 60. Key Industry Trends of Central Nervous System Therapy
Table 61. Central Nervous System Therapy Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Central Nervous System Therapy Distributors List
Table 64. Central Nervous System Therapy Customer List
Table 65. Global Central Nervous System Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Central Nervous System Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Central Nervous System Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Central Nervous System Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Central Nervous System Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Central Nervous System Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Central Nervous System Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Central Nervous System Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Central Nervous System Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Central Nervous System Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Central Nervous System Therapy Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Central Nervous System Therapy Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Central Nervous System Therapy Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Central Nervous System Therapy Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Abbvie Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 80. Abbvie Central Nervous System Therapy Product Portfolios and Specifications
Table 81. Abbvie Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Abbvie Main Business
Table 83. Abbvie Latest Developments
Table 84. Alkermes Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 85. Alkermes Central Nervous System Therapy Product Portfolios and Specifications
Table 86. Alkermes Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Alkermes Main Business
Table 88. Alkermes Latest Developments
Table 89. Allergan Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 90. Allergan Central Nervous System Therapy Product Portfolios and Specifications
Table 91. Allergan Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Allergan Main Business
Table 93. Allergan Latest Developments
Table 94. AstraZeneca Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 95. AstraZeneca Central Nervous System Therapy Product Portfolios and Specifications
Table 96. AstraZeneca Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. AstraZeneca Main Business
Table 98. AstraZeneca Latest Developments
Table 99. BIAL Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 100. BIAL Central Nervous System Therapy Product Portfolios and Specifications
Table 101. BIAL Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. BIAL Main Business
Table 103. BIAL Latest Developments
Table 104. Bristol-myers Squibb Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 105. Bristol-myers Squibb Central Nervous System Therapy Product Portfolios and Specifications
Table 106. Bristol-myers Squibb Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Bristol-myers Squibb Main Business
Table 108. Bristol-myers Squibb Latest Developments
Table 109. Eisai Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 110. Eisai Central Nervous System Therapy Product Portfolios and Specifications
Table 111. Eisai Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Eisai Main Business
Table 113. Eisai Latest Developments
Table 114. Endo Pharmaceuticals Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 115. Endo Pharmaceuticals Central Nervous System Therapy Product Portfolios and Specifications
Table 116. Endo Pharmaceuticals Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Endo Pharmaceuticals Main Business
Table 118. Endo Pharmaceuticals Latest Developments
Table 119. Eli Lilly and Company Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 120. Eli Lilly and Company Central Nervous System Therapy Product Portfolios and Specifications
Table 121. Eli Lilly and Company Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Eli Lilly and Company Main Business
Table 123. Eli Lilly and Company Latest Developments
Table 124. Hoffmann-LA Roche Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 125. Hoffmann-LA Roche Central Nervous System Therapy Product Portfolios and Specifications
Table 126. Hoffmann-LA Roche Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Hoffmann-LA Roche Main Business
Table 128. Hoffmann-LA Roche Latest Developments
Table 1. Central Nervous System Therapy Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Central Nervous System Therapy Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Antidepressant Treatment
Table 4. Major Players of Antipsychotic Therapy
Table 5. Major Players of Other CNS Disorder
Table 6. Global Central Nervous System Therapy Sales by Type (2018-2023) & (K Units)
Table 7. Global Central Nervous System Therapy Sales Market Share by Type (2018-2023)
Table 8. Global Central Nervous System Therapy Revenue by Type (2018-2023) & ($ million)
Table 9. Global Central Nervous System Therapy Revenue Market Share by Type (2018-2023)
Table 10. Global Central Nervous System Therapy Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Central Nervous System Therapy Sales by Application (2018-2023) & (K Units)
Table 12. Global Central Nervous System Therapy Sales Market Share by Application (2018-2023)
Table 13. Global Central Nervous System Therapy Revenue by Application (2018-2023)
Table 14. Global Central Nervous System Therapy Revenue Market Share by Application (2018-2023)
Table 15. Global Central Nervous System Therapy Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Central Nervous System Therapy Sales by Company (2018-2023) & (K Units)
Table 17. Global Central Nervous System Therapy Sales Market Share by Company (2018-2023)
Table 18. Global Central Nervous System Therapy Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Central Nervous System Therapy Revenue Market Share by Company (2018-2023)
Table 20. Global Central Nervous System Therapy Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Central Nervous System Therapy Producing Area Distribution and Sales Area
Table 22. Players Central Nervous System Therapy Products Offered
Table 23. Central Nervous System Therapy Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Central Nervous System Therapy Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Central Nervous System Therapy Sales Market Share Geographic Region (2018-2023)
Table 28. Global Central Nervous System Therapy Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Central Nervous System Therapy Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Central Nervous System Therapy Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Central Nervous System Therapy Sales Market Share by Country/Region (2018-2023)
Table 32. Global Central Nervous System Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Central Nervous System Therapy Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Central Nervous System Therapy Sales by Country (2018-2023) & (K Units)
Table 35. Americas Central Nervous System Therapy Sales Market Share by Country (2018-2023)
Table 36. Americas Central Nervous System Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Central Nervous System Therapy Revenue Market Share by Country (2018-2023)
Table 38. Americas Central Nervous System Therapy Sales by Type (2018-2023) & (K Units)
Table 39. Americas Central Nervous System Therapy Sales by Application (2018-2023) & (K Units)
Table 40. APAC Central Nervous System Therapy Sales by Region (2018-2023) & (K Units)
Table 41. APAC Central Nervous System Therapy Sales Market Share by Region (2018-2023)
Table 42. APAC Central Nervous System Therapy Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Central Nervous System Therapy Revenue Market Share by Region (2018-2023)
Table 44. APAC Central Nervous System Therapy Sales by Type (2018-2023) & (K Units)
Table 45. APAC Central Nervous System Therapy Sales by Application (2018-2023) & (K Units)
Table 46. Europe Central Nervous System Therapy Sales by Country (2018-2023) & (K Units)
Table 47. Europe Central Nervous System Therapy Sales Market Share by Country (2018-2023)
Table 48. Europe Central Nervous System Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Central Nervous System Therapy Revenue Market Share by Country (2018-2023)
Table 50. Europe Central Nervous System Therapy Sales by Type (2018-2023) & (K Units)
Table 51. Europe Central Nervous System Therapy Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Central Nervous System Therapy Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Central Nervous System Therapy Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Central Nervous System Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Central Nervous System Therapy Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Central Nervous System Therapy Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Central Nervous System Therapy Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Central Nervous System Therapy
Table 59. Key Market Challenges & Risks of Central Nervous System Therapy
Table 60. Key Industry Trends of Central Nervous System Therapy
Table 61. Central Nervous System Therapy Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Central Nervous System Therapy Distributors List
Table 64. Central Nervous System Therapy Customer List
Table 65. Global Central Nervous System Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Central Nervous System Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Central Nervous System Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Central Nervous System Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Central Nervous System Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Central Nervous System Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Central Nervous System Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Central Nervous System Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Central Nervous System Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Central Nervous System Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Central Nervous System Therapy Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Central Nervous System Therapy Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Central Nervous System Therapy Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Central Nervous System Therapy Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Abbvie Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 80. Abbvie Central Nervous System Therapy Product Portfolios and Specifications
Table 81. Abbvie Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Abbvie Main Business
Table 83. Abbvie Latest Developments
Table 84. Alkermes Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 85. Alkermes Central Nervous System Therapy Product Portfolios and Specifications
Table 86. Alkermes Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Alkermes Main Business
Table 88. Alkermes Latest Developments
Table 89. Allergan Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 90. Allergan Central Nervous System Therapy Product Portfolios and Specifications
Table 91. Allergan Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Allergan Main Business
Table 93. Allergan Latest Developments
Table 94. AstraZeneca Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 95. AstraZeneca Central Nervous System Therapy Product Portfolios and Specifications
Table 96. AstraZeneca Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. AstraZeneca Main Business
Table 98. AstraZeneca Latest Developments
Table 99. BIAL Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 100. BIAL Central Nervous System Therapy Product Portfolios and Specifications
Table 101. BIAL Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. BIAL Main Business
Table 103. BIAL Latest Developments
Table 104. Bristol-myers Squibb Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 105. Bristol-myers Squibb Central Nervous System Therapy Product Portfolios and Specifications
Table 106. Bristol-myers Squibb Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Bristol-myers Squibb Main Business
Table 108. Bristol-myers Squibb Latest Developments
Table 109. Eisai Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 110. Eisai Central Nervous System Therapy Product Portfolios and Specifications
Table 111. Eisai Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Eisai Main Business
Table 113. Eisai Latest Developments
Table 114. Endo Pharmaceuticals Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 115. Endo Pharmaceuticals Central Nervous System Therapy Product Portfolios and Specifications
Table 116. Endo Pharmaceuticals Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Endo Pharmaceuticals Main Business
Table 118. Endo Pharmaceuticals Latest Developments
Table 119. Eli Lilly and Company Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 120. Eli Lilly and Company Central Nervous System Therapy Product Portfolios and Specifications
Table 121. Eli Lilly and Company Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Eli Lilly and Company Main Business
Table 123. Eli Lilly and Company Latest Developments
Table 124. Hoffmann-LA Roche Basic Information, Central Nervous System Therapy Manufacturing Base, Sales Area and Its Competitors
Table 125. Hoffmann-LA Roche Central Nervous System Therapy Product Portfolios and Specifications
Table 126. Hoffmann-LA Roche Central Nervous System Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Hoffmann-LA Roche Main Business
Table 128. Hoffmann-LA Roche Latest Developments
LIST OF FIGURES
Figure 1. Picture of Central Nervous System Therapy
Figure 2. Central Nervous System Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Central Nervous System Therapy Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Central Nervous System Therapy Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Central Nervous System Therapy Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Antidepressant Treatment
Figure 10. Product Picture of Antipsychotic Therapy
Figure 11. Product Picture of Other CNS Disorder
Figure 12. Global Central Nervous System Therapy Sales Market Share by Type in 2022
Figure 13. Global Central Nervous System Therapy Revenue Market Share by Type (2018-2023)
Figure 14. Central Nervous System Therapy Consumed in Hospital
Figure 15. Global Central Nervous System Therapy Market: Hospital (2018-2023) & (K Units)
Figure 16. Central Nervous System Therapy Consumed in Clinic
Figure 17. Global Central Nervous System Therapy Market: Clinic (2018-2023) & (K Units)
Figure 18. Global Central Nervous System Therapy Sales Market Share by Application (2022)
Figure 19. Global Central Nervous System Therapy Revenue Market Share by Application in 2022
Figure 20. Central Nervous System Therapy Sales Market by Company in 2022 (K Units)
Figure 21. Global Central Nervous System Therapy Sales Market Share by Company in 2022
Figure 22. Central Nervous System Therapy Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Central Nervous System Therapy Revenue Market Share by Company in 2022
Figure 24. Global Central Nervous System Therapy Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Central Nervous System Therapy Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Central Nervous System Therapy Sales 2018-2023 (K Units)
Figure 27. Americas Central Nervous System Therapy Revenue 2018-2023 ($ Millions)
Figure 28. APAC Central Nervous System Therapy Sales 2018-2023 (K Units)
Figure 29. APAC Central Nervous System Therapy Revenue 2018-2023 ($ Millions)
Figure 30. Europe Central Nervous System Therapy Sales 2018-2023 (K Units)
Figure 31. Europe Central Nervous System Therapy Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Central Nervous System Therapy Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Central Nervous System Therapy Revenue 2018-2023 ($ Millions)
Figure 34. Americas Central Nervous System Therapy Sales Market Share by Country in 2022
Figure 35. Americas Central Nervous System Therapy Revenue Market Share by Country in 2022
Figure 36. Americas Central Nervous System Therapy Sales Market Share by Type (2018-2023)
Figure 37. Americas Central Nervous System Therapy Sales Market Share by Application (2018-2023)
Figure 38. United States Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Central Nervous System Therapy Sales Market Share by Region in 2022
Figure 43. APAC Central Nervous System Therapy Revenue Market Share by Regions in 2022
Figure 44. APAC Central Nervous System Therapy Sales Market Share by Type (2018-2023)
Figure 45. APAC Central Nervous System Therapy Sales Market Share by Application (2018-2023)
Figure 46. China Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Central Nervous System Therapy Sales Market Share by Country in 2022
Figure 54. Europe Central Nervous System Therapy Revenue Market Share by Country in 2022
Figure 55. Europe Central Nervous System Therapy Sales Market Share by Type (2018-2023)
Figure 56. Europe Central Nervous System Therapy Sales Market Share by Application (2018-2023)
Figure 57. Germany Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Central Nervous System Therapy Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Central Nervous System Therapy Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Central Nervous System Therapy Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Central Nervous System Therapy Sales Market Share by Application (2018-2023)
Figure 66. Egypt Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Central Nervous System Therapy in 2022
Figure 72. Manufacturing Process Analysis of Central Nervous System Therapy
Figure 73. Industry Chain Structure of Central Nervous System Therapy
Figure 74. Channels of Distribution
Figure 75. Global Central Nervous System Therapy Sales Market Forecast by Region (2024-2029)
Figure 76. Global Central Nervous System Therapy Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Central Nervous System Therapy Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Central Nervous System Therapy Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Central Nervous System Therapy Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Central Nervous System Therapy Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Central Nervous System Therapy
Figure 2. Central Nervous System Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Central Nervous System Therapy Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Central Nervous System Therapy Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Central Nervous System Therapy Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Antidepressant Treatment
Figure 10. Product Picture of Antipsychotic Therapy
Figure 11. Product Picture of Other CNS Disorder
Figure 12. Global Central Nervous System Therapy Sales Market Share by Type in 2022
Figure 13. Global Central Nervous System Therapy Revenue Market Share by Type (2018-2023)
Figure 14. Central Nervous System Therapy Consumed in Hospital
Figure 15. Global Central Nervous System Therapy Market: Hospital (2018-2023) & (K Units)
Figure 16. Central Nervous System Therapy Consumed in Clinic
Figure 17. Global Central Nervous System Therapy Market: Clinic (2018-2023) & (K Units)
Figure 18. Global Central Nervous System Therapy Sales Market Share by Application (2022)
Figure 19. Global Central Nervous System Therapy Revenue Market Share by Application in 2022
Figure 20. Central Nervous System Therapy Sales Market by Company in 2022 (K Units)
Figure 21. Global Central Nervous System Therapy Sales Market Share by Company in 2022
Figure 22. Central Nervous System Therapy Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Central Nervous System Therapy Revenue Market Share by Company in 2022
Figure 24. Global Central Nervous System Therapy Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Central Nervous System Therapy Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Central Nervous System Therapy Sales 2018-2023 (K Units)
Figure 27. Americas Central Nervous System Therapy Revenue 2018-2023 ($ Millions)
Figure 28. APAC Central Nervous System Therapy Sales 2018-2023 (K Units)
Figure 29. APAC Central Nervous System Therapy Revenue 2018-2023 ($ Millions)
Figure 30. Europe Central Nervous System Therapy Sales 2018-2023 (K Units)
Figure 31. Europe Central Nervous System Therapy Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Central Nervous System Therapy Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Central Nervous System Therapy Revenue 2018-2023 ($ Millions)
Figure 34. Americas Central Nervous System Therapy Sales Market Share by Country in 2022
Figure 35. Americas Central Nervous System Therapy Revenue Market Share by Country in 2022
Figure 36. Americas Central Nervous System Therapy Sales Market Share by Type (2018-2023)
Figure 37. Americas Central Nervous System Therapy Sales Market Share by Application (2018-2023)
Figure 38. United States Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Central Nervous System Therapy Sales Market Share by Region in 2022
Figure 43. APAC Central Nervous System Therapy Revenue Market Share by Regions in 2022
Figure 44. APAC Central Nervous System Therapy Sales Market Share by Type (2018-2023)
Figure 45. APAC Central Nervous System Therapy Sales Market Share by Application (2018-2023)
Figure 46. China Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Central Nervous System Therapy Sales Market Share by Country in 2022
Figure 54. Europe Central Nervous System Therapy Revenue Market Share by Country in 2022
Figure 55. Europe Central Nervous System Therapy Sales Market Share by Type (2018-2023)
Figure 56. Europe Central Nervous System Therapy Sales Market Share by Application (2018-2023)
Figure 57. Germany Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Central Nervous System Therapy Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Central Nervous System Therapy Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Central Nervous System Therapy Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Central Nervous System Therapy Sales Market Share by Application (2018-2023)
Figure 66. Egypt Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Central Nervous System Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Central Nervous System Therapy in 2022
Figure 72. Manufacturing Process Analysis of Central Nervous System Therapy
Figure 73. Industry Chain Structure of Central Nervous System Therapy
Figure 74. Channels of Distribution
Figure 75. Global Central Nervous System Therapy Sales Market Forecast by Region (2024-2029)
Figure 76. Global Central Nervous System Therapy Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Central Nervous System Therapy Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Central Nervous System Therapy Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Central Nervous System Therapy Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Central Nervous System Therapy Revenue Market Share Forecast by Application (2024-2029)
